If you compare our positive news to what sava has released not one one person who had not seen the previous price action would believe we were not the company that went to $132/share instead of them. The pendulum is going to swing hard the other direction for us and I believe it will be with no warning.
So what do we have in light of the recent poster presentation? We now have a little more info to work with considering the correlations of PD and AD and the high dose information highly correlated with certain gene activity. Anyone want to put forth their current odds for success when the AD trial reports out?
What we have is a CEO with zero credibility who cherry pics data, misses his own timelines, changes horses in mid stream and moves goal posts. Intuitively, that is what we understand.